|
Gene expression
Citations 1-10 of 221 total displayed.
|
Most recent content
(1 Jun 2008):
|
- Original Articles
Hepatocyte Nuclear Factor 1 and Hypertensive Nephropathy
- Renata I. Dmitrieva, Cruz A. Hinojos, Eric Boerwinkle, Michael C. Braun, Myriam Fornage, and Peter A. Doris
Hypertension 51: 1583 -1589; published online before print as doi:10.1161/HYPERTENSIONAHA.108.110163
[Abstract]
[Full text]
- Original Articles
Liver X Receptor Activator Downregulates Angiotensin II Type 1 Receptor Expression Through Dephosphorylation of Sp1
- Ikuyo Imayama, Toshihiro Ichiki, Dan Patton, Keita Inanaga, Ryohei Miyazaki, Hideki Ohtsubo, Qingping Tian, Kotaro Yano, and Kenji Sunagawa
Hypertension 51: 1631 -1636; published online before print as doi:10.1161/HYPERTENSIONAHA.107.106963
[Abstract]
[Full text]
|
Past content
(since Jan 1999):
|
- Original Articles
Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors
- Arvi Duka, Ekaterina Kintsurashvili, Irena Duka, Deborah Ona, Teresa A. Hopkins, Michael Bader, Irene Gavras, and Haralambos Gavras
Hypertension 51: 1352 -1357; published online before print as doi:10.1161/HYPERTENSIONAHA.107.108506
[Abstract]
[Full text]
- Scientific Contributions
Hepatocyte Nuclear Factor 1 and Hypertensive Nephropathy
- Renata I. Dmitrieva, Cruz A. Hinojos, Eric Boerwinkle, Michael C. Braun, Myriam Fornage, and Peter A. Doris
Hypertension published April 28, 2008, doi:10.1161/HYPERTENSIONAHA.108.110163
[Abstract]
- Scientific Contributions
Liver X Receptor Activator Downregulates Angiotensin II Type 1 Receptor Expression Through Dephosphorylation of Sp1
- Ikuyo Imayama, Toshihiro Ichiki, Dan Patton, Keita Inanaga, Ryohei Miyazaki, Hideki Ohtsubo, Qingping Tian, Kotaro Yano, and Kenji Sunagawa
Hypertension published April 28, 2008, doi:10.1161/HYPERTENSIONAHA.107.106963
[Abstract]
- Original Articles
Interference With PPAR Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling
- Andreas M. Beyer, Gary L. Baumbach, Carmen M. Halabi, Mary L. Modrick, Cynthia M. Lynch, Thomas D. Gerhold, Shams M. Ghoneim, Willem J. de Lange, Henry L. Keen, Yau-Sheng Tsai, Nobuyo Maeda, Curt D. Sigmund, and Frank M. Faraci
Hypertension 51: 867 -871; published online before print as doi:10.1161/HYPERTENSIONAHA.107.103648
[Abstract]
[Full text]
- Go Red Original Articles
Prolonged Ovarian Hormone Deprivation Impairs the Protective Vascular Actions of Estrogen Receptor Agonists
- Christian Pinna, Andrea Cignarella, Paola Sanvito, Valeria Pelosi, and Chiara Bolego
Hypertension 51: 1210 -1217; published online before print as doi:10.1161/HYPERTENSIONAHA.107.106807
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct. Role of the Kinin B1 and B2 Receptors
- Arvi Duka, Ekaterina Kintsurashvili, Irena Duka, Deborah Ona, Teresa A. Hopkins, Michael Bader, Irene Gavras, and Haralambos Gavras
Hypertension published March 17, 2008, doi:10.1161/HYPERTENSIONAHA.107.108506
[Abstract]
- Scientific Contributions
Interference With PPAR Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling
- Andreas M. Beyer, Gary L. Baumbach, Carmen M. Halabi, Mary L. Modrick, Cynthia M. Lynch, Thomas D. Gerhold, Shams M. Ghoneim, Willem J. de Lange, Henry L. Keen, Yau-Sheng Tsai, Nobuyo Maeda, Curt D. Sigmund, and Frank M. Faraci
Hypertension published February 22, 2008, doi:10.1161/HYPERTENSIONAHA.107.103648
[Abstract]
- Scientific Contributions
Interference With PPAR Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling
- Andreas M. Beyer, Gary L. Baumbach, Carmen M. Halabi, Mary L. Modrick, Cynthia M. Lynch, Thomas D. Gerhold, Shams M. Ghoneim, Willem J. de Lange, Henry L. Keen, Yau-Sheng Tsai, Nobuyo Maeda, Curt D. Sigmund, and Frank M. Faraci
Hypertension published February 20, 2008, doi:10.1161/HYPERTENSIONAHA.107.103648
[Abstract]
|
|